Epstein S, Defeudis G, Manfrini S, Napoli N, Pozzilli P
Division of Endocrinology, Mount Sinai School of Medicine, New York, NY, USA.
Unit of Endocrinology and Diabetes, Department of Medicine, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21-00128, Rome, Italy.
Osteoporos Int. 2016 Jun;27(6):1931-51. doi: 10.1007/s00198-015-3454-x. Epub 2016 Mar 15.
Diabetes and osteoporosis are rapidly growing diseases. The link between the high fracture incidence in diabetes as compared with the non-diabetic state has recently been recognized. While this review cannot cover every aspect of diabetic osteodystrophy, it attempts to incorporate current information from the First International Symposium on Diabetes and Bone presentations in Rome in 2014. Diabetes and osteoporosis are fast-growing diseases in the western world and are becoming a major problem in the emerging economic nations. Aging of populations worldwide will be responsible for an increased risk in the incidence of osteoporosis and diabetes. Furthermore, the economic burden due to complications of these diseases is enormous and will continue to increase unless public awareness of these diseases, the curbing of obesity, and cost-effective measures are instituted. The link between diabetes and fractures being more common in diabetics than non-diabetics has been widely recognized. At the same time, many questions remain regarding the underlying mechanisms for greater bone fragility in diabetic patients and the best approach to risk assessment and treatment to prevent fractures. Although it cannot cover every aspect of diabetic osteodystrophy, this review will attempt to incorporate current information particularly from the First International Symposium on Diabetes and Bone presentations in Rome in November 2014.
糖尿病和骨质疏松症是迅速增多的疾病。与非糖尿病状态相比,糖尿病患者骨折发生率较高,二者之间的关联最近已得到认可。虽然本综述无法涵盖糖尿病性骨营养不良的各个方面,但它尝试纳入2014年在罗马举行的第一届糖尿病与骨国际研讨会报告中的当前信息。在西方世界,糖尿病和骨质疏松症是快速增多的疾病,并且在新兴经济体国家正成为一个主要问题。全球人口老龄化将导致骨质疏松症和糖尿病发病率上升。此外,这些疾病并发症造成的经济负担巨大,除非提高公众对这些疾病的认识、控制肥胖以及采取具有成本效益的措施,否则负担将持续增加。糖尿病患者比非糖尿病患者骨折更为常见,这一关联已得到广泛认可。与此同时,关于糖尿病患者骨脆性增加的潜在机制以及预防骨折的最佳风险评估和治疗方法,仍存在许多问题。虽然本综述无法涵盖糖尿病性骨营养不良的各个方面,但它将尝试纳入当前信息,特别是来自2014年11月在罗马举行的第一届糖尿病与骨国际研讨会报告中的信息。